First Results and Experience with PRRT in South Africa.

about

First Results and Experience with PRRT in South Africa.

Item

http://www.wikidata.org/entity/Q55231659

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

First Results and Experience with PRRT in South Africa.

@en

First Results and Experience with PRRT in South Africa.

@nl

type

Item

label

First Results and Experience with PRRT in South Africa.

@en

First Results and Experience with PRRT in South Africa.

@nl

prefLabel

First Results and Experience with PRRT in South Africa.

@en

First Results and Experience with PRRT in South Africa.

@nl

P1476

First Results and Experience with PRRT in South Africa.

@en

P2093

C S Corbett

http://www.w3.org/2001/XMLSchema#string

I O Lawal

http://www.w3.org/2001/XMLSchema#string

John R Buscombe

http://www.w3.org/2001/XMLSchema#string

M R Modiselle

http://www.w3.org/2001/XMLSchema#string

Mariza Vorster

http://www.w3.org/2001/XMLSchema#string

Mike M Sathekge

http://www.w3.org/2001/XMLSchema#string

P2860

How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies

High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours

Gastroenteropancreatic neuroendocrine tumours

Prognostic Value of Volume-Based Metabolic Parameters Measured by (18)F-FDG PET/CT of Pancreatic Neuroendocrine Tumors.

Effect of Peptide Receptor Radionuclide Therapy on Somatostatin Receptor Status and Glucose Metabolism in Neuroendocrine Tumors: Intraindividual Comparison of Ga-68 DOTANOC PET/CT and F-18 FDG PET/CT.

²¹³Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours.

Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.

Peptides and receptors in image-guided therapy: theranostics for neuroendocrine neoplasms.

P304

86-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/WJNM.WJNM_25_17

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29719482

http://www.w3.org/2001/XMLSchema#string

P921

Aafrikaa Kibbaa

P932

5905263

http://www.w3.org/2001/XMLSchema#string